ArticleApplied biochemistry and biotechnology2024

Loureirin B inhibits Cervical Cancer Development by Blocking PI3K/AKT Signaling Pathway: Network Pharmacology Analysis and Experimental Validation.

Yinwen Hong et al.PubMed ↗Publisher ↗

No numbers read from the abstract.